Topics
- How to navigate the barriers and facilitators to exploit product listing agreements
- A complete and thorough understanding of the concrete regulatory changes and guidance from the PMPRB
- Practical solutions and strategies for bulk purchasing initiatives
- Developing Canada-wide strategies for generics
- Untangling the pathway for oncology and rare disease drugs
Who should Attend
Biotech, Pharmaceutical and GenericPresidents, Vice Presidents, Directors, Managers and Analysts of: Reimbursement, Pricing, Brand Managers, Sales, Investor Relations, Pharmacy Services, Regulatory Affairs, Market Access, Government Relations, Policy and Compliance, Business Development, Marketing, National Trade and Formularies.
